Principal Scientist
Genentech
South San Francisco, California, United States
Dr. Moussion received her PhD from the University of Toulouse (France) where she studied the mechanisms controlling the migration of
lymphocytes from blood to tissues. She then moved to IST Austria in Vienna as a Postdoctoral fellow in the group of Michael Sixt to study the control of Dendritic cells migration from the periphery to the draining lymph node through the lymphatic circulation. In 2016, Dr. Moussion joined Genentech (San Francisco, CA) as a team leader in the Cancer Immunology Department. Her group bridges basic science and drug discovery focusing on deciphering new cellular and molecular mechanisms controlling the recruitment of leukocytes in the context of an anti-tumor Immune response. By combining innovative in vivo and ex vivo imaging techniques with genetic and pharmacological tools her group pursues new basic discoveries and reverse translational research effort from human pathology to mouse models to improve the outcome of Immunotherapies in the treatment of solid tumors.
Disclosure information not submitted.
Thursday, June 23, 2022
10:00 AM – 10:25 AM PT
